Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription


1 Acta Psychiatr Scand
2 Biol Psychiatry
2 J Clin Psychiatry
1 Mol Psychiatry
1 Neurosci Lett
1 Proc Natl Acad Sci U S A
3 Psychiatry Res
2 Psychol Med
4 Schizophr Res

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Acta Psychiatr Scand

  1. FACAL F, Arrojo M, Paz E, Paramo M, et al
    Association between psychiatric hospitalizations of patients with schizophrenia and polygenic risk scores based on genes with altered expression by antipsychotics.
    Acta Psychiatr Scand. 2022 May 18. doi: 10.1111/acps.13444.
    PubMed         Abstract available

    Biol Psychiatry

  2. DIENEL SJ, Schoonover KE, Lewis DA
    Cognitive Dysfunction and Prefrontal Cortical Circuit Alterations in Schizophrenia: Developmental Trajectories.
    Biol Psychiatry. 2022 Mar 10. pii: S0006-3223(22)01072.
    PubMed         Abstract available

  3. BENOIT LJ, Canetta S, Kellendonk C
    Thalamocortical Development: A Neurodevelopmental Framework for Schizophrenia.
    Biol Psychiatry. 2022 Mar 14. pii: S0006-3223(22)01074.
    PubMed         Abstract available

    J Clin Psychiatry

  4. ZHENG S, Lee J, Chan SKW
    Utility and Barriers to Clozapine Use: A Joint Study of Clinicians' Attitudes From Singapore and Hong Kong.
    J Clin Psychiatry. 2022;83.
    PubMed         Abstract available

  5. WEIDEN PJ, Breier A, Kavanagh S, Miller AC, et al
    Antipsychotic Efficacy of KarXT (Xanomeline-Trospium): Post Hoc Analysis of Positive and Negative Syndrome Scale Categorical Response Rates, Time Course of Response, and Symptom Domains of Response in a Phase 2 Study.
    J Clin Psychiatry. 2022;83.
    PubMed         Abstract available

    Mol Psychiatry

  6. MOJARAD BA, Engchuan W, Trost B, Backstrom I, et al
    Genome-wide tandem repeat expansions contribute to schizophrenia risk.
    Mol Psychiatry. 2022 May 12. pii: 10.1038/s41380-022-01575.
    PubMed         Abstract available

    Neurosci Lett

  7. ZHANG M, Hong X, Yang F, Fan H, et al
    Structural brain imaging abnormalities correlate with positive symptom in schizophrenia.
    Neurosci Lett. 2022 May 17:136683. doi: 10.1016/j.neulet.2022.136683.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  8. VELEANU M, Urrieta-Chavez B, Sigoillot SM, Paul MA, et al
    Modified climbing fiber/Purkinje cell synaptic connectivity in the cerebellum of the neonatal phencyclidine model of schizophrenia.
    Proc Natl Acad Sci U S A. 2022;119:e2122544119.
    PubMed         Abstract available

    Psychiatry Res

  9. KATZ IR, Szymanski BR, Marder SR, Shotwell A, et al
    Comparative risks of all-cause mortality for Veterans with schizophrenia with ongoing receipt of clozapine and other antipsychotic medications.
    Psychiatry Res. 2022;313:114590.
    PubMed         Abstract available

  10. XU L, Hao D, Wei Y, Cui H, et al
    Effect of cognitive insight on clinical insight from pre-morbid to early psychosis stages.
    Psychiatry Res. 2022;313:114613.
    PubMed         Abstract available

  11. CAO X, Chen S, Xu H, Wang Q, et al
    Global functioning, cognitive function, psychopathological symptoms in untreated patients with first-episode schizophrenia: A cross-sectional study.
    Psychiatry Res. 2022;313:114616.
    PubMed         Abstract available

    Psychol Med

  12. DESOUZA DD, Tang SX, Danilewitz M
    The burgeoning role of speech and language assessment in schizophrenia spectrum disorders.
    Psychol Med. 2022 May 18:1-2. doi: 10.1017/S0033291722001325.

  13. CULBERT KM, Thakkar KN, Klump KL
    Risk for midlife psychosis in women: critical gaps and opportunities in exploring perimenopause and ovarian hormones as mechanisms of risk.
    Psychol Med. 2022 May 18:1-9. doi: 10.1017/S0033291722001143.
    PubMed         Abstract available

    Schizophr Res

  14. SANCHEZ-TORRES AM, Peralta V, Gil-Berrozpe GJ, Mezquida G, et al
    The network structure of cognitive deficits in first episode psychosis patients.
    Schizophr Res. 2022;244:46-54.
    PubMed         Abstract available

  15. ALONSO-SANCHEZ MF, Limongi R, Gati J, Palaniyappan L, et al
    Language network self-inhibition and semantic similarity in first-episode schizophrenia: A computational-linguistic and effective connectivity approach.
    Schizophr Res. 2022 May 11. pii: S0920-9964(22)00160.
    PubMed         Abstract available

  16. CARRA G, Crocamo C, Bartoli F, Angermeyer M, et al
    Influence of positive and negative symptoms on hedonic and eudaemonic well-being in people with schizophrenia: A longitudinal analysis from the EuroSc study.
    Schizophr Res. 2022;244:21-28.
    PubMed         Abstract available

    Commentary on whether progressive brain change underlies the pathology of schizophrenia: Should this even be debated?
    Schizophr Res. 2022;244:18-20.

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.